Packaging development field

Pharmaceutical and medical packaging | Establishing traceability verification within the boundaries of paper-based outer packaging

This development area focuses on paper-based outer packaging of pharmaceuticals and medical products. First clarify the packaging level, product sensitivity, storage and transportation, sealing and regulatory attributes, and then determine the paper material, structure, testing and evidence requirements.

Typical objectsMedical cartons, medical product outer boxes, paper-based inner trays, instructions and transportation protection structures
What to complete first?Packaging levels, product attributes, contact relationships, sealing, storage, transportation and target markets
Open boundariesBy default, only outer packaging will be discussed, and other high-risk uses will be subject to specific project judgment.
Confirm the packaging level first
Outer packaging

Can continue to be publicly understood

direct contact

Requires special pre-examination

Sterile or sterile

Enter the high-risk special path

Define the packaging hierarchy first, then create validation questions.

Currently entering from paper-based outer packaging and secondary packaging, issues are organized according to product sensitivity, sealing, storage, transportation and documentation requirements.

Moisture Barrier Targets and Product Sensitivity

How packaging layers, closures, storage conditions and product sensitivities connect to outer packaging moisture barrier goals.

Sealing and Structural Integrity

How heat-sealed or glued structures control cracking, peeling, fiber tearing and structural failure in transit.

Particle and cleaning management

How paper dusting, trimming, rubbing, die-cutting and converting processes require identifying and recording particle risks.

Material Compatibility and Extractables

Only after the materials, contact relationships, product attributes, and regulatory scope are clear can the need for a dedicated program be determined.

Aging, transportation and traceability

How sample versions, batches, storage, transportation, aging conditions and changes are traceable.

Standard scope of application

Topics such as terminal sterilization device packaging, sterility barriers and ISO 11607 will only be judged as applicable within the specific project.

PROJECT HANDOFF

First determine the packaging hierarchy, and then make each role responsible for the same object.

This field defaults to entry from paper-based outer packaging and secondary packaging. Direct contact, sterile barrier or sterilization uses require separate special prequalification.

PAPER MILL

Paper mill

Provides records of paper identity, surface, moisture effects, paper powder, trimming, batch and supply changes.

COATER

Coating plant

Provides coating structure, coating and drying conditions, moisture barrier stability, cleaning and deviation information.

CONVERTER

Product processing companies

Printing, die-cutting, folding, bonding, sealing, granulation, shipping and traceability conditions are available.

BRAND OWNER

Terminal brand

Provide packaging levels, product sensitivity, storage and transportation, target markets and documentation requirements.

Pharmaceutical and medical packaging are promoted along five project nodes.

First confirm the scope of outer packaging or secondary packaging, and then form candidate structures, equipment testing, product verification and traceability evidence.

  1. 01 Project conditions

    Confirm packaging levels, product sensitivity, storage and transportation, failure and acceptance goals.

  2. 02 Route screening and proofing

    Lock down paper stock, inner support, functional layers, inks, adhesives, seals and candidate material routes.

  3. 03 Adaptation of papermaking and coating

    Evaluate coating, drying, printing, cleaning, defects, moisture barrier and equipment stability windows.

  4. 04 Pilot test and product verification

    Use representative outer packaging to review sealing, granulation, structure, aging, transportation and traceability.

  5. 05 Evidence delivery and introduction review

    Bind packaging levels, sample batches, method versions, markets, file permissions and change control.

EVIDENCE BOUNDARY

Pharmaceutical and medical packaging currently focuses on paper-based outer packaging and secondary packaging.

By default, this page establishes a verification path around the moisture-proof, sealing, cleanliness, transportation, traceability and regulatory information of paper-based outer packaging and secondary packaging; direct contact, sterile barrier, terminal sterilization and efficacy topics will only enter controlled items after special pre-examination.

  • ISO 11607 only determines applicability in terminal sterilization medical device packaging projects.
  • The topics of direct contact, sterile barriers, sterilization and efficacy must be transferred to dedicated review and verification.
  • Any results must be tied to packaging levels, sample versions, test conditions, target markets and access rights.

First, clearly explain the outer packaging objects and responsibility boundaries.

Submit packaging level, product attributes, paper material, structure, closure, storage and transportation, target market and known information. The platform first conducts a scope pre-review before deciding on disclosure, project conditions, or controlled paths.

BIOTEN DEVELOPER

Bring this object back into the development loop.

Continue defining variables, validation requirements and information access, or submit a development task for manual pre-review.